Nicholas Investment Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Nicholas Investment Partners’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-325,548	Closed	-$12.8M	–	215
2023 Q2	$12.8M	Buy	+325,548	New	+$11.5M	0.88%	38
2023 Q1	–	Sell	-209,976	Closed	-$4.5M	–	223
2022 Q4	$4.5M	Hold	209,976	–	–	0.39%	80
2022 Q3	$3.77M	Sell	209,976 -1,080,077	-84%	-$14.2M	0.35%	88
2022 Q2	$12.4M	Buy	1,290,053 +196,377	+18%	+$2.46M	1.17%	25
2022 Q1	$18.4M	Buy	1,093,676 +553,946	+103%	+$8.19M	1.31%	20
2021 Q4	$9.02M	Buy	+539,730	New	+$8.85M	0.57%	66
2016 Q4	–	Sell	-53,577	Closed	-$2.47M	–	350
2016 Q3	$2.47M	Sell	53,577 -10,950	-17%	-$618K	0.16%	236
2016 Q2	$3.29M	Buy	+64,527	New	+$3.21M	0.23%	179

Nicholas Investment Partners's ISEE Position: Q3 2023 in Review

Nicholas Investment Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 325,548 shares — an estimated $12.8M sold.

Nicholas Investment Partners first reported a position in ISEE in Q2 2016 and held it in 8 quarters. The position peaked at $18.4M in Q1 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Nicholas Investment Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Nicholas Investment Partners sold 325,548 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $12.8M.
Nicholas Investment Partners first reported a position in IVERIC bio, Inc. Common Stock in Q2 2016 and held it in 8 quarters.
Nicholas Investment Partners's IVERIC bio, Inc. Common Stock position peaked at $18.4M in Q1 2022.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Nicholas Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.